Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
36.36
-1.93 (-5.04%)
Jun 10, 2026, 10:41 AM EDT - Market open

Astrana Health Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Astrana Health stock has a consensus rating of "Strong Buy" and an average price target of $46. The average 1-year stock price forecast is 26.51% higher than the current stock price, while the lowest is $41 (+12.76%) and the highest is $50 (+37.51%).

Price Target: $46 (+26.51%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$41$46$45$50
Change+12.76%+26.51%+23.76%+37.51%

Analyst Ratings

The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy888888
Buy111112
Hold222221
Sell000000
Strong Sell000000
Total111111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 1, 2026
Barclays
Barclays
Buy
Upgrades
$37$50
BuyUpgrades$37$50+37.51%May 26, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 13, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$35$45
BuyReiterates$35$45+23.76%May 12, 2026
Robert W. Baird
Robert W. Baird
Buy
Maintains
$40$45
BuyMaintains$40$45+23.76%May 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.00B
from 3.18B
Increased by 25.82%
Revenue Next Year
4.38B
from 4.00B
Increased by 9.35%
EPS This Year
2.92
from 2.12
Increased by 37.57%
EPS Next Year
3.41
from 2.92
Increased by 16.78%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
773.92M1.14B1.39B2.03B3.18B4.00B
Revenue Growth
12.62%47.84%21.19%46.72%56.39%25.82%
Gross Profit
177.77M199.48M214.96M271.39M341.53M444.37M
Gross Margin
22.97%17.43%15.50%13.34%10.73%11.10%
Operating Income
98.18M104.27M84.61M89.35M98.13M159.10M
Net Income
68.92M45.17M60.72M43.15M22.49M62.31M
EPS
----2.122.92
EPS Growth
----45.92%37.57%
Forward PE
63.3565.7630.6225.0229.9512.45
Free Cash Flow
33.57M88.27M74.56M65.92M227.95M118.23M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.1B
Avg4.0B
Low3.9B

Revenue Growth

Revenue Growth202620272028
High
28.5%
Avg
25.8%
Low
24.1%

EPS Forecast

EPS202620272028
High2.99
Avg2.92
Low2.85

EPS Growth

EPS Growth202620272028
High
40.9%
Avg
37.6%
Low
34.3%